Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Lutterotti

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Current Opinion in Neurology|April 3, 2018
Challenges and needs in experimental therapies for multiple sclerosisAndreas Lutterotti
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|February 19, 2017
Is it Time for Immunotherapy Trials in Narcolepsy?Andreas Lutterotti
Seminars in Immunology|February 12, 2026
Therapeutic immune tolerance for central nervous system autoimmune diseases - Prospects, challenges and pitfallsAndreas Lutterotti, Roland Martin
Expert Opinion on Investigational Drugs|October 25, 2013
Antigen-specific tolerization approaches in multiple sclerosisAndreas Lutterotti, Roland Martin
The Lancet. Neurology|May 20, 2008
Getting specific: monoclonal antibodies in multiple sclerosisAndreas Lutterotti, Roland Martin
Current Medicinal Chemistry|August 21, 2007
Biological markers for multiple sclerosisAndreas Lutterotti, Thomas Berger, Markus Reindl
Journal of the Neurological Sciences|July 5, 2008
Antigen-specific therapies in MS - Current concepts and novel approachesAndreas Lutterotti, Mireia Sospedra, Roland Martin
Frontiers in Immunology|January 24, 2022
Mechanistic and Biomarker Studies to Demonstrate Immune Tolerance in Multiple SclerosisMaría José Docampo, Andreas Lutterotti, Mireia Sospedra, et al.
Frontiers in Immunology|April 8, 2021
Antigen-Specific Immune Tolerance in Multiple Sclerosis-Promising Approaches and How to Bring Them to PatientsAndreas Lutterotti, Helen Hayward-Koennecke, Mireia Sospedra, et al.
Sleep|April 2, 2017
CD4+ T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1Melanie Ramberger, Birgit Högl, Ambra Stefani, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Current Opinion in Neurology|April 3, 2018
Challenges and needs in experimental therapies for multiple sclerosisAndreas Lutterotti
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|February 19, 2017
Is it Time for Immunotherapy Trials in Narcolepsy?Andreas Lutterotti
Seminars in Immunology|February 12, 2026
Therapeutic immune tolerance for central nervous system autoimmune diseases - Prospects, challenges and pitfallsAndreas Lutterotti, Roland Martin
Expert Opinion on Investigational Drugs|October 25, 2013
Antigen-specific tolerization approaches in multiple sclerosisAndreas Lutterotti, Roland Martin
The Lancet. Neurology|May 20, 2008
Getting specific: monoclonal antibodies in multiple sclerosisAndreas Lutterotti, Roland Martin
Current Medicinal Chemistry|August 21, 2007
Biological markers for multiple sclerosisAndreas Lutterotti, Thomas Berger, Markus Reindl
Journal of the Neurological Sciences|July 5, 2008
Antigen-specific therapies in MS - Current concepts and novel approachesAndreas Lutterotti, Mireia Sospedra, Roland Martin
Frontiers in Immunology|January 24, 2022
Mechanistic and Biomarker Studies to Demonstrate Immune Tolerance in Multiple SclerosisMaría José Docampo, Andreas Lutterotti, Mireia Sospedra, et al.
Frontiers in Immunology|April 8, 2021
Antigen-Specific Immune Tolerance in Multiple Sclerosis-Promising Approaches and How to Bring Them to PatientsAndreas Lutterotti, Helen Hayward-Koennecke, Mireia Sospedra, et al.
Sleep|April 2, 2017
CD4+ T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1Melanie Ramberger, Birgit Högl, Ambra Stefani, et al.
Pageof 7